Propel Bio Management LLC 13D and 13G filings for Eiger BioPharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-11-02 9:54 pm Purchase | 2023-11-02 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 179,174 12.130% | 9,275 (+5.46%) | Filing |
| 2023-10-20 4:29 pm Purchase | 2023-10-18 | 13D | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 169,900 11.510% | 9,102 (+5.66%) | Filing |
| 2023-09-28 4:54 pm Purchase | 2023-09-14 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 160,798 10.900% | 81,059 (+101.66%) | Filing |
| 2023-08-15 06:00 am Purchase | 2023-08-02 | 13G | Eiger BioPharmaceuticals, Inc. EIGR | Propel Bio Management LLC | 79,739 5.400% | 79,739 (New Position) | Filing |